Mangoceuticals (NASDAQ:MGRX) Stock Price Up 18% – What’s Next?

Shares of Mangoceuticals, Inc. (NASDAQ:MGRXGet Free Report) traded up 18% during mid-day trading on Wednesday . The stock traded as high as $4.69 and last traded at $4.27. 217,098 shares traded hands during mid-day trading, a decline of 4% from the average session volume of 226,555 shares. The stock had previously closed at $3.62.

Mangoceuticals Stock Performance

The firm has a market cap of $11.09 million, a P/E ratio of -0.77 and a beta of 1.51. The stock’s 50-day moving average is $3.78 and its 200 day moving average is $14.67.

Mangoceuticals (NASDAQ:MGRXGet Free Report) last announced its quarterly earnings results on Thursday, March 20th. The company reported ($1.01) earnings per share (EPS) for the quarter. Mangoceuticals had a negative return on equity of 138.00% and a negative net margin of 1,237.00%. The business had revenue of $0.11 million during the quarter.

About Mangoceuticals

(Get Free Report)

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.

Further Reading

Receive News & Ratings for Mangoceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mangoceuticals and related companies with MarketBeat.com's FREE daily email newsletter.